The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

69 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-01

Study Completion Date

2021-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the researchers planned to compare the treatment results of patients undergoing rubber band ligation in addition to drug therapy in hemorrhagic internal hemorrhoids patients and those treated only with anti-hemorrhoidal drugs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Rubber Band Ligation and Milligan-Morgan Hemorrhoidectomy for the Treatment of Grade II-III Internal Hemorrhoids: a Multicenter, Non-randomized Controlled Study

NCT06794151

Hemorrhoid

ACTIVE_NOT_RECRUITING

Comparison Between Single and Triple Rubber Band Ligation for the Treatment of Hemorrhoids

NCT01383577

Second-degree Hemorrhoids

UNKNOWN NA

Trial of Latex Vs Non-latex Hemorrhoid Banding

NCT06625138

Hemorrhoid Hemorrhoid Bleeding

RECRUITING NA

The Two Treatment Methods Compared the Sclerosing Agent Injection and the Rubber Wrapping

NCT05089500

Hemorrhoid Hemorrhoids Hemorrhoids Internal +3 more

UNKNOWN NA

Hemorrhoid Artery LigatioN Without Doppler Trial

NCT04119401

Hemorrhoids

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Introduction: Band ligation is one of the most frequently used methods in the treatment of hemorrhagic internal hemorrhoidal disease. Also, phlebotonic use and surgical excision options are available as an anti-hemorrhoidal drug in the treatment of the disease. Many studies have shown that these methods are safe to use. Band ligation is used quite often in our clinic. Whether or not band ligation is performed, these patients are prescribed phlebotonics as an anti-hemorrhoidal drug.

Purpose: In this study, investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti hemorrhoidal drug.

Method: The study was planned prospectively and observationally. Patients are not assigned to groups by the researcher. The researcher cannot interfere with the treatment method given to the patient. The method of treatment is the method approved by the patient's doctor.

Patients diagnosed with internal hemorrhoids will be examined in a group of patients who are prescribed anti-hemorrhoidal drugs and rubber band ligation in the context of routine treatment.

In the other group, again, in the form of routine treatment, patients who are not given rubber band ligation and who are given only anti-hemorrhoidal drugs will be examined.

Group 1: Patients who have been prescribed 450 mg diosmin + 50 mg hesperidin as an anti-hemorrhoidal drug and rubber band ligation will be included in this group.

Group 2: Patients who have been prescribed only 450 mg of diosmin + 50 mg of hesperidin as treatment, without rubber band ligation will be included in this group.

Patients will undergo a control examination in the 21 days after treatment.

* Whether the bleeding continues?
* Which bleeding day stopped?
* The comfort of the anal area will be evaluated
* Did the side effect develop?
* Did any complications occur? The above information will be entered into the SPSS program, and statistical analysis will be done.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemorrhoids, Internal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Band ligation and phlebotonic group

Patients with rubber band ligation and the prescribed anti hemorrhoidal drug will be examined in this group.

(Note: The researcher has no contribution or intervention to the treatment method.)

band ligation

Intervention Type PROCEDURE

Rubber band ligation will be applied to patients, and then phlebotonic will be prescribed.

(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)

oral 450 mg diosmin+50 mg hesperidin

Intervention Type DRUG

450 mg diosmin + 50 mg hesperidin will be prescribed to patients undergoing band ligation.

(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)

Only phlebotonic group

Patients who are prescribed the only 450mg of diosmin + 50mg of hesperidin as a treatment for bleeding internal hemorrhoids will be examined in this group.

(Note: The researcher has no contribution or intervention to the treatment method.)

oral 450 mg diosmin+50 mg hesperidin

Intervention Type DRUG

450 mg diosmin + 50 mg hesperidin will be prescribed to patients undergoing band ligation.

(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

band ligation

Rubber band ligation will be applied to patients, and then phlebotonic will be prescribed.

(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)

Intervention Type PROCEDURE

oral 450 mg diosmin+50 mg hesperidin

450 mg diosmin + 50 mg hesperidin will be prescribed to patients undergoing band ligation.

(Note: The researcher has no contribution or intervention to the treatment method. Patients receiving this treatment will be observed.)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients diagnosed with internal hemorrhoids with an anamnesis + examination + rectoscope.

Exclusion Criteria

* Patients under 18 years old
* Patients over 65 years old
* Pregnant
* Chronic liver patients
* Those with bleeding disorders
* Patients taking anti-coagulants and anti-aggregates
* Patients with colorectal cancer.
* Those who have had hemorrhoid surgery before

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes